Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Stock

Equities

300018

CNE100000GP0

Electrical Components & Equipment

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-20 pm EDT 5-day change 1st Jan Change
5 CNY -2.15% Intraday chart for Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. -3.29% -18.17%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2022 443M 61.18M Sales 2023 448M 61.91M Capitalization 2.94B 406M
Net income 2022 8M 1.11M Net income 2023 60M 8.29M EV / Sales 2022 5.23 x
Net cash position 2022 606M 83.73M Net cash position 2023 678M 93.61M EV / Sales 2023 5.04 x
P/E ratio 2022
304 x
P/E ratio 2023
47 x
Employees 732
Yield 2022
0.82%
Yield 2023
0.82%
Free-Float 70.82%
More Fundamentals * Assessed data
Dynamic Chart
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Approves Cash Dividend for the Year 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Wuhan Zhongyuan Huadian Chairman Resigns; Vice Chairman Succeeds MT
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. cancelled the transaction announced on April 26, 2020 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Implements Cash Dividend for the Year 2022, Payable on 30 June 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Approves Cash Dividend for the Year 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Biaodi Electronics announced that it has received $1.5 million in funding from Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. CI
More news
1 day-2.15%
1 week-3.29%
Current month-0.40%
1 month+2.88%
3 months+10.38%
6 months-20.89%
Current year-18.17%
More quotes
1 week
4.96
Extreme 4.96
5.32
1 month
4.66
Extreme 4.66
5.45
Current year
3.43
Extreme 3.43
6.26
1 year
3.43
Extreme 3.43
7.18
3 years
3.43
Extreme 3.43
9.18
5 years
3.43
Extreme 3.43
10.85
10 years
3.26
Extreme 3.26
34.50
More quotes
Managers TitleAgeSince
Founder 65 01-11-15
Director of Finance/CFO 53 11-10-19
Chairman 63 01-10-31
Members of the board TitleAgeSince
President 51 01-10-31
Chairman 57 01-10-31
Founder 65 01-11-15
More insiders
Date Price Change Volume
24-05-20 5 -2.15% 10 790 330
24-05-20 5.11 +0.20% 9,345,200
24-05-17 5.1 +1.19% 10,220,700
24-05-16 5.04 -1.37% 11,882,300
24-05-15 5.11 -4.49% 21,445,400

End-of-day quote Shenzhen S.E., May 20, 2024

More quotes
WUHAN ZHONGYUAN HUADIAN SCIENCE & TECHNOLOGY CO., LTD. is a China-based company principally engaged in the research, development, manufacture and sales of electrical power system intelligent record analysis products, time synchronization products, transformer substation integrated automation systems and automated distribution equipment, as well as the provision of related services for its products. The Company operates through two main segments. The Transmission and Distribution and Control Equipment Manufacturing segment is mainly engaged in the research, development, manufacture and sales of power failure recording devices, time synchronization devices, substation integrated automation system and distribution automation equipment. The Medical Health segment is engaged in the research, development and manufacture of medical information products and in-vitro diagnostic equipment.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300018 Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW